Evidence map›Paper›PMID 37762768›Full record

ArticleJournal of clinical medicine2023

Effectiveness and Tolerability of Ectoin

Don Lorenzo Constantin Roventa, Ursula Pieper-Fürst, Cengizhan Acikel, Dunia Santos, Ulrike Sent, Ralph Mösges

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Don Lorenzo Constantin RoventaInstitute of Medical Statistics and Bioinformatics (IMSB), Faculty of Medicine, University of Cologne, 50924 Cologne, Germany.
Ursula Pieper-FürstClinCompetence Cologne GmbH, Theodor-Heuss-Ring 14, 50668 Cologne, Germany.
Cengizhan AcikelClinCompetence Cologne GmbH, Theodor-Heuss-Ring 14, 50668 Cologne, Germany.ORCID 0000-0001-5699-4305
Dunia SantosSanofi, 65926 Frankfurt, Germany.ORCID 0009-0007-3878-1155
Ulrike SentSanofi, 65926 Frankfurt, Germany.
Ralph MösgesInstitute of Medical Statistics and Bioinformatics (IMSB), Faculty of Medicine, University of Cologne, 50924 Cologne, Germany.ORCID 0000-0002-1928-810X
Sanofi (Germany) · DEUniversity of Cologne · DE

Funding

Sanofi N/A
6 · The paper itself

Abstract

Acute pharyngitis can cause sore throat. This multicentre, active-controlled, randomised, open-label, and parallel-group study, conducted according to the German Medical Devices Act, compared the effectiveness and tolerability of ERS09 mouth and throat spray with a well-established device for the treatment of sore throat caused by acute pharyngitis and dry cough. Patients were randomised 1:1 into ERS09/comparator groups (EMSER

Indexed as

acute pharyngitisdry coughectoinesore throatthroat spraytreatment device

Identifiers

PMID37762768
PMCPMC10531782
OpenAlexW4386496120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.